Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer.

Abstract

No abstract available.

EDRN PI Authors
  • (None specified)
Medline Author List
  • Arredouani MS
  • Dunn LK
  • Kissick HT
  • Sanda MG
PubMed ID
Appears In